Fumaric acid esters in the treatment of psoriasis

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 237-238

  Anstey, A V ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARIC ACID;

DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; MAINTENANCE THERAPY; NOTE; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; SIDE EFFECT; TREATMENT DURATION;

DERMATOLOGIC AGENTS; ESTERS; FUMARATES; GREAT BRITAIN; HUMANS; PSORIASIS;

EID: 74349123960     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09624.x     Document Type: Note

References (5)

1. Wain EM, Darling MI, Pleass RD et al. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol 2010 162
2. Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol 1999 141 : 424 429.
3. Naldi L, Griffiths CEM. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. Br J Dermatol 2005 152 : 597 615.
4. Sizto S, Bansback N, Feldman SR et al. Economic evaluation of systemic therapies for moderate to severe psoriasis. Br J Dermatol 2009 160 : 1264 1272.
5. Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003 149 : 363 369.